These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 235572)

  • 21. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term phase reorganization of conditioned food aversion memory in edible snail.
    Kozyrev SA; Solntseva SV; Nikitin VP
    Bull Exp Biol Med; 2014 Aug; 157(4):416-20. PubMed ID: 25110074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the reported protective effect of cycloheximide on memory.
    Davis HP; Rosenzweig MR; Grove EA; Bennett EL
    Pharmacol Biochem Behav; 1984 Mar; 20(3):405-13. PubMed ID: 6709675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interaction of sydnocarb with preparations influencing the metabolism of catecholamines].
    Al'tshuler RA; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1976; 39(1):9-14. PubMed ID: 943326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery from amnesia induced by pre-test injections of monoamine oxidase inhibitors.
    Botwinick CY; Quartermain D
    Pharmacol Biochem Behav; 1974 May; 2(3):375-9. PubMed ID: 4858168
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of drugs on amines in the CNS.
    Sulser F; Sanders-Bush E
    Annu Rev Pharmacol; 1971; 11():209-30. PubMed ID: 4948498
    [No Abstract]   [Full Text] [Related]  

  • 28. Variable decay of memory and its recovery in cycloheximide-treated mice.
    Squire LR; Barondes SH
    Proc Natl Acad Sci U S A; 1972 Jun; 69(6):1416-20. PubMed ID: 4504352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral catecholamines and memory: characteristics of syrosingopine-induced amnesia.
    Walsh TJ; Palfai T
    Pharmacol Biochem Behav; 1979 Oct; 11(4):449-52. PubMed ID: 42929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors.
    Juorio AV; Greenshaw AJ; Wishart TB
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):644-8. PubMed ID: 3149722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interaction with cholinergic drugs in reversal of cycloheximide-induced amnesia by thyrotropin-releasing hormone and its analog DN-1417 in mice].
    Yamazaki N; Shintani M; Saji Y; Nagawa Y
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):127-36. PubMed ID: 6431710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential activity of enantiomers of amphetamine in rats.
    Maickel RP; Light KE; Zabik JE
    Neuropharmacology; 1982 Dec; 21(12):1323-7. PubMed ID: 6218425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar effects of a monoamine oxidase inhibitor and a sympathomimetic amine on memory formation.
    Gibbs ME; Ng KT
    Pharmacol Biochem Behav; 1979 Sep; 11(3):335-9. PubMed ID: 504314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetoxycycloheximide-induced transient amnesia: protective effects of adrenergic stimulants.
    Serota RG; Roberts RB; Flexner LB
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):340-2. PubMed ID: 4333977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal and pharmacological parameters of puromycin-induced amnesia.
    Barraco RA; Frank KE
    Pharmacol Biochem Behav; 1983 May; 18(5):809-15. PubMed ID: 6682979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of retrieval enhancement by amphetamine following scopolamine-induced amnesia.
    Quartermain D; Jung H
    Pharmacol Biochem Behav; 1989 May; 33(1):51-4. PubMed ID: 2780787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of the effects of d-amphetamine and morphine upon the locomotor activity of mice treated with drugs which alter brain catecholamine content.
    Villarreal JE; Guzman M; Smith CB
    J Pharmacol Exp Ther; 1973 Oct; 187(1):1-7. PubMed ID: 4746328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.